Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etonogestrel Contraceptive Implant at Scapular Site
NCT07201402Phase 2Recruiting
- Sponsor
- Yale University
- Start
- May 2026
- Primary completion
- May 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of etonogestrel in contraception, sponsored by Yale University. Primary endpoint: Serum etonogestrel concentrations at 36 months. Started May 2026; status: recruiting.
02
Drugs
etonogestrel
03
Conditions
contraception
Beyond the preview
Go deeper on NCT07201402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07201402.